Abstract: A washing machine appliance includes a tub and a rotatable basket therein. Methods of operating the washing machine appliance may include, and/or the washing machine appliance may be configured for, measuring a first inertia of a load of articles in the basket by rotating the basket at rotational speeds outside of a resonance speed zone. A water extraction operation is performed after measuring the first inertia of the load of articles. The water extraction operation includes rotating the basket at speeds outside of the resonance speed zone. A second inertia of the load of articles after the water extraction operation is measured by rotating the basket at rotational speeds outside of the resonance speed zone. A load type of the load of articles is determined based on the second inertia. The basket is rotated at speeds within the resonance speed zone only once prior to the water extraction operation.

Abstract: Techniques for allocating hydrocarbon production include receiving a selection of a particular area identification (ID) of a plurality of area IDs stored on the server; determining based on the selected particular area ID, a plurality of hydrocarbon production values that include periodic area-level hydrocarbon production values associated with the particular area ID and a plurality of wells associated with the particular area ID; determining a decline curve model for the area-level hydrocarbon production values associated with the particular area ID; modeling the aggregated periodic well-level hydrocarbon production values with the determined decline curve model; and determining allocated well-level hydrocarbon production values based at least in part on the selected decline curve model to display at a client device.

Abstract: A charging device can include a base that includes power transmission circuitry, a charger panel and a coil operatively coupled to the power transmission circuitry, where the charger panel includes a transparent material, and where the coil is visible via the transparent material.

Abstract: Some embodiments include compounds that can inhibit the growth of bacterial and/or inhibit or reduce microbial infections caused by one or more microorganisms (e.g., Pseudomonas aeruginosa and Cryptococcus neoformans) and methods of using these compounds to treat microbial infection and outbreaks and/or to reduce the formation of biofilms. Other embodiments include synthesis of the compounds that can inhibit the growth of one or more microorganisms and/or inhibit or reduce microbial infections.

Abstract: The present invention discloses gas and moisture vapor barrier coating compositions that comprise an amine modified polyvinyl alcohol and an acetoacetate modified polyvinyl. The barrier coatings of the invention exhibit enhanced gas and moisture vapor properties. The barrier coatings of the invention maintain gas and moisture vapor properties even after repeated flexing of a coated substrate.

Abstract: Described are methods for providing a pulsed dose of nitric oxide during at least the first two-thirds of total inspiratory time in each single breath for a therapeutically relevant period of time.

Abstract: Some embodiments include compounds that can inhibit the growth of bacterial and/or inhibit or reduce microbial infections caused by one or more microorganisms (e.g., Pseudomonas aeruginosa and Cryptococcus neoformans) and methods of using these compounds to treat microbial infection and outbreaks and/or to reduce the formation of biofilms. Other embodiments include synthesis of the compounds that can inhibit the growth of one or more microorganisms and/or inhibit or reduce microbial infections.

Abstract: Some embodiments include compounds that can inhibit the growth of bacterial and/or inhibit or reduce microbial infections caused by one or more microorganisms (e.g., Pseudomonas aeruginosa and Cryptococcus neoformans) and methods of using these compounds to treat microbial infection and outbreaks and/or to reduce the formation of biofilms. Other embodiments include synthesis of the compounds that can inhibit the growth of one or more microorganisms and/or inhibit or reduce microbial infections.

Abstract: A method and apparatus for using a solar energy reflecting article, encompassing at least one ordered arrangement of reflector elements, each of which elements has a relatively flat, highly reflective face at an angle of primary reflection, with said article designed for a particular solar installation, such that when the article is appropriately placed between rows of bifacial solar photovoltaic modules or underneath the modules, solar energy that would otherwise strike the ground (or supporting surface, such as a rooftop) is instead, when said solar energy strikes the article from at least one angle within at least one defined range of angles relative to the solar reflecting article, reflected onto the side of at least one bifacial module that faces away from the sun. In this manner the article will increase the amount of electricity produced by at least one bifacial solar photovoltaic module.

Abstract: A process for recovering non-ferrous metals from a solid matrix may include: (a) leaching the solid matrix with an aqueous-based solution containing chloride ions, ammonium ions, and Cu2+ ions, having a pH of 6.5-8.5, in a presence of oxygen, at a temperature of 100° C.-160° C. and a pressure of 150 kPa-800 kPa, so as to obtain an extraction solution comprising leached metals and solid leaching residue; (b) separating the solid leaching residue from the extraction solution; and/or (c) subjecting the extraction solution to at least one cementation so as to recover the leached metals in elemental state. The pH may be greater than or equal to 6.5 and less than or equal to 8.5. Temperature may be greater than or equal to 100° C. and less than or equal to 160° C. Pressure may be greater than or equal to 150 kPa and less than or equal to 800 kPa.

Abstract: The present invention discloses gas and moisture vapor barrier coating compositions that comprise an amine modified polyvinyl alcohol and an acetoacetate modified polyvinyl. The barrier coatings of the invention exhibit enhanced gas and moisture vapor properties. The barrier coatings of the invention maintain gas and moisture vapor properties even after repeated flexing of a coated substrate.

Abstract: A quick connect handlebar assembly for a motorcycle is disclosed. The handlebar assembly consists of an elongated handlebar having a plurality of motorcycle control components pre-mounted thereto, including indicator lights, throttle controls, gear change controls, turn signal controls and the like. A riser is mounted to a hub portion of the handlebar assembly which is mountable to the riser mount of the motorcycle by a pair of elongated bolts. A plurality of control cables and wires extend from the various motorcycle control components mounted on the handlebar assembly through the handlebar and out of the hub portion. The handlebar assembly is configured to be quickly attached or removed from the motorcycle by means of the elongated pair of elongated bolts.

Abstract: Certain compounds, or pharmaceutically acceptable salts or prodrugs thereof, are provided herein. Also provided are pharmaceutical compositions comprising at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of KMO activity are described, which comprise administering to such patients an amount of at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include neurodegenerative disorders such as Huntington's disease.

Abstract: Some embodiments include compounds that can inhibit the growth of bacterial and/or inhibit or reduce microbial infections caused by one or more microorganisms (e.g., Pseudomonas aeruginosa and Cryptococcus neoformans) and methods of using these compounds to treat microbial infection and outbreaks and/or to reduce the formation of biofilms. Other embodiments include synthesis of the compounds that can inhibit the growth of one or more microorganisms and/or inhibit or reduce microbial infections.

Abstract: Certain compounds, or pharmaceutically acceptable salts or prodrugs thereof, are provided herein. Also provided are pharmaceutical compositions comprising at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of KMO activity are described, which comprise administering to such patients an amount of at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include neurodegenerative disorders such as Huntington's disease.

Abstract: A process for recovering non-ferrous metals from a solid matrix may include: (a) leaching the solid matrix with an aqueous-based solution containing chloride ions, ammonium ions, and Cu2+ ions, having a pH of 6.5-8.5, in a presence of oxygen, at a temperature of 100° C.-160° C. and a pressure of 150 kPa-800 kPa, so as to obtain an extraction solution comprising leached metals and solid leaching residue; (b) separating the solid leaching residue from the extraction solution; and/or (c) subjecting the extraction solution to at least one cementation so as to recover the leached metals in elemental state. The pH may be greater than or equal to 6.5 and less than or equal to 8.5. Temperature may be greater than or equal to 100° C. and less than or equal to 160° C. Pressure may be greater than or equal to 150 kPa and less than or equal to 800 kPa.

Abstract: A process for recovering non-ferrous metals from a solid matrix may include: leaching the solid matrix with an aqueous-based solution, in a presence of oxygen, to obtain an extraction solution including leached metals and solid leaching residue; separating the solid leaching residue from the extraction solution; and subjecting the extraction solution to at least one cementation to recover the leached metals in elemental state. The leaching solution may include chloride ions. The leaching solution may further include ammonium ions. A pH of the leaching solution may be greater than or equal to 6.5 and less than or equal to 8.5. A leaching temperature may be greater than or equal to 100° C. and less than or equal to 160° C. A leaching pressure may be greater than or equal to 150 kPa and less than or equal to 800 kPa.

Abstract: Certain compounds, or pharmaceutically acceptable salts or prodrugs thereof, are provided herein. Also provided are pharmaceutical compositions comprising at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of KMO activity are described, which comprise administering to such patients an amount of at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include neurodegenerative disorders such as Huntington's disease.